An open-label prospective study of restless legs patients switched to ropinirole from pramipexole to help determine the equipotent dose.

Trial Profile

An open-label prospective study of restless legs patients switched to ropinirole from pramipexole to help determine the equipotent dose.

Completed
Phase of Trial: Phase IV

Latest Information Update: 17 Aug 2016

At a glance

  • Drugs Ropinirole (Primary) ; Pramipexole
  • Indications Restless legs syndrome
  • Focus Therapeutic Use
  • Acronyms SWITCH
  • Most Recent Events

    • 11 May 2011 Actual end date (Apr 2010) added as reported by ClinicalTrials.gov.
    • 11 May 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 04 Nov 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top